LRMR Competitors & Alternatives
Compare Larimar Therapeutics Inc with similar stocks in the same industry
Biotechnology
LRMR
Main Stock$2.96
Tradestie Score
54
Market Cap
$355.20M
Analyst Upside
+386.5%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$15.51
|
$354.45M | - | 61 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$36.99
|
$353.70M | - | 64 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.72
|
$350.98M | - | 55 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.74
|
$341.56M | - | 37 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$4.19
|
$332.96M | - | 69 | Compare |
|
REPL
Replimune Group, Inc.
|
$13.07
|
$328.62M | - | 65 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.24
|
$307.12M | - | 42 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.18
|
$304.12M | - | 54 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$14.12
|
$297.23M | - | 55 | Compare |
|
OMER
Omeros Corporation
|
$18.61
|
$281.75M | 11.2 | 54 | Compare |
More LRMR Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry